CCB: calcium channel blockers; COVID-19: coronavirus disease 2019

: Potential substantially increased exposure of the medications; these drugs should not be prescribed together.

: Potential moderately increased exposure of the medications; dosage adjustment or close monitoring may be required.

: Potential mildly increased exposure of the medications; the interactions are weak

-: No significant effects

Data about drug-drug interactions presented in this table were adopted from the work by Liverpool Drug Interactions Group which could be found at the following website: https://www.covid19-druginteractions.org⁶³

Table 2. Pharmacokinetics of medications for atrial fibrillation and COVID-19.

COVID-19: coronavirus disease 2019